Physician profile
Emily Murphy
NPI 1396307997
$700.54
in general payments reported to CMS, 2019-2025
13 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3.17 · 2022: $80.65 · 2024: $238 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $413.82 | 2024-2025 | Grafix Pl, Grafix, Stravix |
| Lifenet Health | $53.62 | 2025 | Theragenesis Wound Matrix |
| Convatec INC. | $45.28 | 2024 | |
| Kerecis Limited | $31.24 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Supernus Pharmaceuticals, INC. | $28.28 | 2022 | |
| Reapplix INC. | $22.05 | 2025 | 3c Patch Kit - Box |
| Bausch Health US, LLC | $21.28 | 2022 | |
| Integra Lifesciences Corporation | $17.75 | 2025 | Integra, Omnigraft, Surgimend |
| Merck Sharp & Dohme LLC | $16.84 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.77 | 2024 | Nuzyra |
| Hologic Sales and Service, LLC | $16.19 | 2024 | Localizer |
| Novo Nordisk INC | $14.25 | 2022 | |
| Genentech USA, INC. | $3.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.